SARAH ESTESS: Open Payments
NPI 1588088827 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,058 in 113 payments from 23 companies in 2025. Trend: 2023 $1,869 · 2024 $1,954 · 2025 $2,058
Food & beverage: $2,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $489 |
| PFIZER INC. | 16 | $262 |
| Novo Nordisk Inc | 12 | $216 |
| Inspire Medical Systems, Inc. | 2 | $184 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $140 |
| Lilly USA, LLC | 8 | $122 |
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| Corcept Therapeutics | 3 | $77 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| Amgen Inc. | 3 | $65 |
Products named: QULIPTA, VRAYLAR, INSPIRE, Ozempic, Kerendia, UBRELVY, NURTEC ODT, MOUNJARO.
Industry payments across LA — which companies pay providers there.
